Treatment of retained placenta with misoprostol: A randomised controlled trial in a low-resource setting (Tanzania)

BMC Pregnancy and Childbirth

Volumn 9, Issue , 2009, Pages 48-

  van Beekhuizen, Heleen J ^a   Pembe, Andrea B ^b   Fauteck, Heiner ^c   Lotgering, Fred K ^d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c UNIVERSITY OF LÜBECK   (Germany)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; PLACEBO;

ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; GESTATIONAL AGE; HUMAN; MATERNAL CARE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RETAINED PLACENTA;

ADMINISTRATION, SUBLINGUAL; CLINICAL PROTOCOLS; DEVELOPING COUNTRIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MISOPROSTOL; OXYTOCICS; PLACENTA, RETAINED; PREGNANCY; RESEARCH DESIGN; TANZANIA;

EID: 70450267528     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-9-48     Document Type: Article

References (24)

1. Oxorn H. Human Labor & Birth. Human Labor & Birth 1986, 555-565. London: Prentice-Hall, Oxorn H, 4.
2. Weeks A. The retained placenta. Best Practice & Research Clinical Obstetrics & Gynaecology 2008, 22:1103-1117. 10.1016/j.bpobgyn.2008.07.005, 18793876.
3. Ministry of Health, United Republic of Tanzania. Safe motherhood reference manual for district level 2000,
4. Bais JM, Eskes M, Pel M, Bonsel GJ, Bleker OP. Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women. A Dutch population-based cohort study on standard (> or = 500 ml) and severe (> or = 1000 ml) postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 2004, 115:166-172. 15262350.
5. Dombrowski MP, Bottoms SF, Saleh AA, Hurd WW, Romero R. Third stage of labor: Analysis of duration and clinical practice. American Journal of Obstetrics and Gynecology 1995, 172:1279-1284. 10.1016/0002-9378(95)91493-5, 7726270.
6. WHO The world health report: make every mother and child count 2005, , http://www.who.int/whr/2005/en/index.html
7. Demographic and Health Surveys Tanzania. http://www.measuredhs.com/pubs/pub_details.cfm?ID=566., http://www.measuredhs.com/pubs/pdf/FR173/09Chapter09.pdf
8. MacLeod J, Rhode R. Retrospective follow-up of maternal deaths and their associated risk factors in a rural district of Tanzania. Trop Med Int Health 1998, 3:130-137. 10.1046/j.1365-3156.1998.00174.x, 9537275.
9. Tandberg A, Albrechtsen S, Iversen OE. Manual removal of the placenta. Incidence and clinical significance. Acta Obstet Gynecol Scand 1999, 78:33-36. 10.1034/j.1600-0412.1999.780108.x, 9926889.
10. Romero R, Hsu YC, Athanassiadis AP, Hagay ZH, Avilia C, Nores J. Preterm Delivery: A risk factor for retained placenta. Am J Obstet Gynecol 1990, 163(3):823-825. 2403163.
11. Beekhuizen van HJ, Vierhout ME. The recurrence risk of retained placenta. Nederlands Tijdschrift voor Geneeskunde 1994, 138:2149-2152.
12. Khan GQ, John IS, Wani S, Dohety T, Sibai BM. Controlled cord traction versus minimal intervention techniques in delivery of the placenta: a randomized controlled trial. Am J Obstet Gynecol 1997, 177:770-774. 10.1016/S0002-9378(97)70266-7, 9369817.
13. Coker A, Oliver R. Definitions and classifications. A textbook of postpartum hemorrhage 2006, 1:11-16. Duncow, UK: Sapiens Publishing, Lynch CB, Keith LG, Lalonde CB, Karoshi M.
14. Carroli G, Bergel E. Umbilical vein injection for management of retained placenta. Cochrane Database of Systematic Reviews 2001, CD001337. 10.1002/14651858.CD001337.
15. van Beekhuizen HJ, de Groot AN, De Boo T, Burger D, Jansen N, Lotgering FK. Sulprostone reduces the need for the manual removal of the placenta in patients with retained placenta: a randomized controlled trial. Am J Obstet Gynecol 2006, 194:446-450. 10.1016/j.ajog.2005.08.029, 16458644.
16. Rogers MSYP, Wong S. Avoiding manual Removal of the placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta. Acta Obs Gynaecol 2007, 86:48-56.
17. van Stralen G, Roosmalen van JJM. Letter to Editor. Acta Obs Gynaecol 2007, 86:764. 10.1080/00016340701330054.
18. Tang OS, Schweer H, Seybert HW, Lee SWH, Ho PC. Pharmacokinetics of different routes of administartion of misoprostol. Human Reproduction 2002, 17:332-336. 10.1093/humrep/17.2.332, 11821273.
19. Weeks A, Faundes A. Misoprostol in obstetrics and gynecology. Int J Gynaecol Obstet 2007, 99(Suppl 2):S156-159. 10.1016/j.ijgo.2007.09.003, 17961572.
20. Misoprostol in obstetrics and gynaecology. , http://www.misoprostol.org/File/guidelines.php
21. Hofmeyr GJ, Walraven G, Gülmezoglu AM, Maholwana B, Alfirevic Z, Villar J. Misoprostol to treat postpartum haemorrhage: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology 2005, 112:547-553. 10.1111/j.1471-0528.2004.00512.x.
22. Surbeck DV, Fehr PM, Hosli I, Holzgreve W. Oral misoprostol for the third stage of labor: a randomized placebo-controlled trial. Am J Obstet Gynecol 1999, 94:255-258.
23. Walley RL, Wilson JB, Crane JMG, Matthews K, Sawyer E, Hutchens D. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour. BJOG: An International Journal of Obstetrics & Gynaecology 2000, 107:1111-1115.
24. Ng PS, Chan ASM, Sin WK, Tang LCH, Cheung KB, Yuen PM. A multicentre randomized controlled trial of oral misoprostol and i.m. syntometrine in the management of the third stage of labour. Hum Reprod 2001, 16:31-35. 10.1093/humrep/16.1.31, 11139532.